Company Profiles

driven by the PitchBook Platform

Applied Proteomics

Description

Developer of a diagnostics platform designed to offer protein-based molecular diagnostics. The company's diagnostics platform offers a protein bio-marker discovery platform to advance the application of proteomics to the development of diagnostics, companion diagnostics, and personalized medicine applications, providing users with protein-based biomarker for industrial application and ready to be applied to health diagnostic problems.

PRIVATE

Status

51-200

Employees

Series C

Latest Deal Type

$28M

Latest Deal Amount

$54.5M

Total Amount Raised

5

Investors

Description

Developer of a diagnostics platform designed to offer protein-based molecular diagnostics. The company's diagnostics platform offers a protein bio-marker discovery platform to advance the application of proteomics to the development of diagnostics, companion diagnostics, and personalized medicine applications, providing users with protein-based biomarker for industrial application and ready to be applied to health diagnostic problems.

Website:

www.appliedproteomics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Discovery Tools (Healthcare)

Primary Office

3545 John Hopkins Court Suite 150 San Diego, CA 92121United States +1 (858) 999-2800
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Applied Proteomics's full profile, request a free trial.

Applied Proteomics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Applied Proteomics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Applied Proteomics Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Domain AssociatesVenture CapitalMinority000 0000000 0000
Genting BerhadHolding CompanyMinority000 0000000 0000
Genting GenomicsCorporationMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Vulcan CapitalVenture CapitalMinority000 0000000 0000
Domain Associates Venture Capital
Genting Berhad Holding Company
Genting Genomics Corporation
Individual Investor Angel (individual)
Vulcan Capital Venture Capital

Applied Proteomics Executive Team (13)

NameTitleBoard
Seat
Contact
Info
Peter Klemm Ph.DPresident & Chief Executive Officer
Premal Shah Ph.DChief Executive Officer
Jeffrey BlackChief Financial Officer
William LaRueBoard Member
Lisa Croner Ph.DDirector, Bioinformatics and Software Development
Peter Klemm Ph.D President & Chief Executive Officer
Premal Shah Ph.D Chief Executive Officer
Jeffrey Black Chief Financial Officer
William LaRue Board Member
Lisa Croner Ph.D Director, Bioinformatics and Software Development

Applied Proteomics Board Members (9)

NameRepresentingRoleSinceContact
Info
Daniel AbrutynSelfBoard Member000 0000
David Agus MDApplied ProteomicsCo-Founder & Board Member000 0000
Erik Holmlin Ph.DSelfBoard Member000 0000
James Blair Ph.DDomain AssociatesPartner000 0000
Kin ChongApplied ProteomicsBoard Member000 0000
Daniel Abrutyn Board Member Self
David Agus MD Co-Founder & Board Member Applied Proteomics
Erik Holmlin Ph.D Board Member Self
James Blair Ph.D Partner Domain Associates
Kin Chong Board Member Applied Proteomics
Request full access to PitchBook